Corporate DisclosureSQURPHARMA
SQURPHARMA Corporate Disclosure — 18 November 2020
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 18 November 2020. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
The auditor of the Square Pharmaceuticals Ltd has given the "Emphasis of Matter " paragraph in the Auditor's Report for the year ended on 30 June 2020. Emphasis of Matter: We draw attention to the note no. 8 to the separate financial statements, which describes the loans given to subsidiaries and associates as well as companies with common directors. The company obtained approval for such loans from the Board of Directors. Our opinion is not modified in this regard. (cont.)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace8c5a6b0000400552b7
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.